United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin otic solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: otitis externa in adults and pediatric patients, 6 months and older, due to escherichia coli, pseudomonas aeruginosa, and staphylococcus aereus . chronic suppurative otitis media in patients 12 years and older with perforated tympanic membranes due to proteus mirabilis, pseudomonas aeruginosa and staphylococcus aureus . acute otitis media in pediatric patients one year and older with tympanostomy tubes due to haemophilus influenzae, moraxella catarrhalis, pseudomonas aeruginosa, staphylococcus aureus, and streptococcus pneumoniae . ofloxacin otic solution 0.3% is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: conjunctivitis: gram-positive bacteria: staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae gram-negative bacteria: enterobacter cloacae haemophilus influenzae proteus mirabilis pseudomonas aeruginosa corneal ulcers: gram-positive bacteria: staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae   gram-negative bacteria: pseudomonas aeruginosa serratia marcescens* anaerobic species: propionibacterium acnes *efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: conjunctivitis: gram-positive bacteria: staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae gram-negative bacteria: enterobacter cloacae haemophilus influenzae proteus mirabilis pseudomonas aeruginosa corneal ulcers: gram-positive bacteria: staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae   gram-negative bacteria: pseudomonas aeruginosa serratia marcescens*  anaerobic species: propionibacterium acnes *efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

keltman pharmaceuticals inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: staphylococcus aureus staphylococcus epidermidis enterobacter cloacae haemophilus influenzae proteus mirabilis pseudomonas aeruginosa staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae pseudomonas aeruginosa serratia marcescens* *efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

stat rx llc usa - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: staphylococcus aureus staphylococcus epidermidis enterobacter cloacae haemophilus influenzae proteus mirabilis pseudomonas aeruginosa staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae pseudomonas aeruginosa serratia marcescens* *efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

h.j. harkins company, inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication. please follow these instructions carefully when using ofloxacin ophthalmic solution. use ofloxacin ophthalmic solution as prescribed by your doctor. - if you use other topically applied ophthalmic medications, they should be administered at least 10 minutes before or after the use of ofloxacin ophthalmic solution. - wash hands before each use. -   tighten the cap on the nozzle till the cap touches the shoulder. tighten the cap on the nozzle till the cap touches the shoulder. -   the spike in the cap will pierce the tip of the bottle. to open the bottle unscrew the cap the spike in the cap will pierce the tip of the bottle. to open the bottle unscrew the cap -   tilt your

United States - English - NLM (National Library of Medicine)

fdc limited - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: * efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

direct rx - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: *efficacy for this organism was studied in fewer than 10 infections ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication (see warnings ).

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: ofloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication (see warnings ).